Dr. Reddy’s Q2 and H1 FY17 Financial Results

Go back to Dr. Reddy’s Q2 and H1 FY17 Financial Results

Dr. Reddys Labs (RDY) Reports Q2 EPS of $0.27

October 25, 2016 7:24 AM EDT

Dr. Reddys Labs (NYSE: RDY) reported Q2 EPS of $0.27, versus $0.63 reported last year. Revenue for the quarter came in at $539 billion, versus $599 billion reported last year.

Commenting on the results, Co-chairman and CEO, G V Prasad said, All our major businesses have shown... More